BRAF inhibitor or BRAF/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer. - Finkel I; Korzets Y; Moore A; Coreanu T; Popovtzer A; Shoffel-Havakuk H; Bachar G; Mansour J; Weiss C; Robenshtok E (Archives of endocrinology and metabolism, 2025)